Story perspectives

Hang Seng Index Rises: Lithium Stocks Surge Amid Drug Approval

9/16/2025

Summary

Story summary

The Hang Seng Index increased by 0.22% to 26,446.56 points, with a turnover of HKD 290.195 billion, reflecting a consolidation phase amid lower trading volume.
Lithium battery stocks, especially CATL, rose over 7% due to strong demand and favorable policies, with a CLSA report forecasting a 37% profit growth for CATL this year.
Innovative drug stocks gained significantly, with PharmAbcine-B surging 115.58% after receiving tacit clinical approval for its breast cancer treatment.
The automotive sector aims for 32.3 million annual vehicle sales by 2025, with new energy vehicle sales projected at 15.5 million units.
Fudan Microelectronics declined by 3.77% after being added to the U.S. Entity List but reported increased strategic reserves to stabilize operations.

History

Historical Context

The 2015 stock market crash in China prompted significant reforms in trading regulations and investor protections, leading to a turnover of HKD 290.195 billion on the Hong Kong Stock Exchange. As the lithium battery sector thrives, companies like CATL project a 37% profit growth, aligning with the automotive industry's goal of 15.5 million new energy vehicle sales by 2025, marking a shift towards sustainable technologies.

1 of 2

Story summary

The Hang Seng Index increased by 0.22% to 26,446.56 points, with a turnover of HKD 290.195 billion, reflecting a consolidation phase amid lower trading volume.
Lithium battery stocks, especially CATL, rose over 7% due to strong demand and favorable policies, with a CLSA report forecasting a 37% profit growth for CATL this year.
Innovative drug stocks gained significantly, with PharmAbcine-B surging 115.58% after receiving tacit clinical approval for its breast cancer treatment.
The automotive sector aims for 32.3 million annual vehicle sales by 2025, with new energy vehicle sales projected at 15.5 million units.
Fudan Microelectronics declined by 3.77% after being added to the U.S. Entity List but reported increased strategic reserves to stabilize operations.

1 / 2